Industry / United Kingdom
MHRA Release New Counterfeit Plan
November 2007 | Industry NewsThe UK medicines and Healthcare Products Regulatory Agency (MHRA) has released a new strategy or 2007-2011 to combat counterfeit medicines. The move has come after nine batches of counterfeit medicines were recalled in the past three years, suggesting that the supply chain has become increasingly vulnerable.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
